Evidence map›Paper›PMID 32154588›Full record

ArticleAlcoholism, clinical and experimental research2020

Inhibition of Receptor Protein Tyrosine Phosphatase β/ζ Reduces Alcohol Intake in Rats.

Javier Calleja-Conde, Rosalía Fernández-Calle, José M Zapico, Ana Ramos, Beatriz de Pascual-Teresa, Kora-Mareen Bühler, Victor Echeverry-Alzate, Elena Giné, Fernando Rodríguez de Fonseca, Jose Antonio López-Moreno and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Alcoholism, clinical and experimental research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Alcohol and the brain: from genes to circuits.Trends in neurosciences · 2021
    Review
  5. The Immune System through the Lens of Alcohol Intake and Gut Microbiota.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Javier Calleja-CondeFrom the, Department of Psychobiology and Behavioral Sciences Methods, (JC-C, K-MB, VE-A, JAL-M), School of Psychology, Complutense University of Madrid, Madrid, Spain.
Rosalía Fernández-CalleDepartamento de Ciencias Farmacéuticas y de la Salud, (RF-C, GH), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Alcorcón, Spain.
José M ZapicoDepartamento de Química y Bioquímica, (JMZ, AR, BP-T), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Alcorcón, Spain.
Ana RamosDepartamento de Química y Bioquímica, (JMZ, AR, BP-T), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Alcorcón, Spain.
Beatriz de Pascual-TeresaDepartamento de Química y Bioquímica, (JMZ, AR, BP-T), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Alcorcón, Spain.
Kora-Mareen BühlerFrom the, Department of Psychobiology and Behavioral Sciences Methods, (JC-C, K-MB, VE-A, JAL-M), School of Psychology, Complutense University of Madrid, Madrid, Spain.
Victor Echeverry-AlzateFrom the, Department of Psychobiology and Behavioral Sciences Methods, (JC-C, K-MB, VE-A, JAL-M), School of Psychology, Complutense University of Madrid, Madrid, Spain.
Elena GinéDepartment of Cellular Biology, (EG), School of Medicine, Complutense University of Madrid, Madrid, Spain.
Fernando Rodríguez de FonsecaLaboratorio de Medicina Regenerativa, (VE-A, FRF), Hospital Regional Universitario Carlos Haya, Fundación IMABIS, Málaga, Spain.
Jose Antonio López-MorenoFrom the, Department of Psychobiology and Behavioral Sciences Methods, (JC-C, K-MB, VE-A, JAL-M), School of Psychology, Complutense University of Madrid, Madrid, Spain.
Gonzalo HerradónDepartamento de Ciencias Farmacéuticas y de la Salud, (RF-C, GH), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Alcorcón, Spain.ORCID 0000-0002-1578-3744
Universidad Complutense de Madrid · ESUniversidad San Pablo CEU · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPleiotrophin (PTN) and midkine (MK) are cytokines that are up-regulated in the prefrontal cortex (PFC) after alcohol administration and have been shown to reduce alcohol intake and reward. Both cytokines are endogenous inhibitors of receptor protein tyrosine phosphatase (RPTP) β/ζ (a.k.a. PTPRZ1). Recently, a new compound named MY10 was designed with the aim of mimicking the activity of PTN and MK. MY10 has already shown promising results regulating alcohol-related behaviors in mice.

methodsWe have now tested the effects of MY10 on alcohol operant self-administration and Drinking In the Dark-Multiple Scheduled Access (DID-MSA) paradigms in rats. Gene expression of relevant genes in the PTN/MK signaling pathway in the PFC was analyzed by real-time PCR.

resultsMY10, at the highest dose tested (100 mg/kg), reduced alcohol consumption in the alcohol operant self-administration paradigm (p = 0.040). In the DID-MSA paradigm, rats drank significantly less alcohol (p = 0.019) and showed a significant decrease in alcohol preference (p = 0.002). We observed that the longer the exposure to alcohol, the greater the suppressing effects of MY10 on alcohol consumption. It was demonstrated that the effects of MY10 were specific to alcohol since saccharin intake was not affected by MY10 (p = 0.804). MY10 prevented the alcohol-induced down-regulation of Ptprz1 (p = 0.004) and anaplastic lymphoma kinase (Alk; p = 0.013) expression.

conclusionsOur results support and provide further evidence regarding the efficacy of MY10 on alcohol-related behaviors and suggest the consideration of the blockade of RPTPβ/ζ as a target for reducing excessive alcohol consumption.

Indexed as

Alcohol DrinkingAnimalsCarrier ProteinsCytokinesDose-Response Relationship, DrugEnzyme InhibitorsGene ExpressionMaleMidkineRatsRats, WistarReceptor-Like Protein Tyrosine Phosphatases, Class 5Signal TransductionCarrier ProteinsCytokinesEnzyme InhibitorsMidkinepleiotrophinReceptor-Like Protein Tyrosine Phosphatases, Class 5Alcohol Use DisorderALKMidkinePleiotrophin

Identifiers

PMID32154588
OpenAlexW3012435737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.